97318 ⎘
Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
Compositions and methods for identifying enzyme and transport protein inhibitors
#302Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
#303Targeted delivery system
#304Methods for identifying and isolating cells expressing a polypeptide
#305Expression vector containing the major envelope protein P9 of cystovirus PHI6 as a fusion partner, and process for producing a membrane protein using the same
#306Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
#307Cell surface display of polypeptide isoforms by stop codon readthrough
#308based delivery system and methods of use
#309Yeast Display Systems
#310Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
#311Helicobacter system and uses thereof
#312Construction of protrophic/celluloytic yeast strains expressing tethered and secreted cellulases
#313Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria
#314Antibody Targeting Through a Modular Recognition Domain
#315Antigenic compositions and use of same in the targeted delivery of nucleic acids
#316SUPPRESSION OF NEUROENDOCRINE DISEASES
#317Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
#318Suppression of neuroendocrine diseases
#319SUPPRESSION OF CANCERS
#320Recombinant bacteriophage and methods for their use
#321System for the expression of peptides on the bacterial surface
#322Oral delivery of modified transferrin fusion proteins
#323Transferrin fusion protein libraries
#324Multivalent clostridial toxins
#325Chimeric Phage Tail Proteins and Uses Thereof
#326REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS
#327ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF
#328Mutant antibody Fc domains and fusion proteins thereof
#329Regulated apoptosis
#330METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#331DRUG DELIVERY SYSTEMS USING FC FRAGMENTS
#332Cell surface display, screening and production of proteins of interest
#333based delivery system and methods of use
#334Yeast-based vaccines
#335Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
#336EXPRESSION OF FULL LENGTH IGG AND SECRETION INTO THE CULTURE MEDIUM OF PROKARYOTIC CELLS
#337Phage displayed cell binding peptides
#338Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef
#339Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
#340TARGETED BIOCIDES
#341Method and means for enrichment, removal and detection of gram-positive bacteria
#342Use of VEGF-C or VEGF-D in Reconstructive Surgery
#343Chimeric proteins for measuring atp concentrations in pericellular space and related screening method
#344Crystal structure of clumping factor A in complex with fibrinogen derived peptide and uses thereof
#345Chimeric fusion proteins
#346Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#347Phage derived antimicrobial activities
#348Expression vectors
#349GROWTH FACTOR
#350Nonviral vectors for delivering polynucleotides to target tissues
#351Method for generating tethered proteins
#352Modified toxins
#353system and uses thereof
#354Methods and compositions related to targeting tumors and wounds
#355Proteins for use in human and animal infections
#356Targeted protein replacement for the treatment of lysosomal storage disorders
#357Method for producing insulin analogs having a dibasic B chain terminus
#358Immunoglobulin Fc libraries
#359Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine
#360Immunoglobulin Directed Biocides
#361Regulated transcription of targeted genes and other biological events
#362Multivalent clostridial toxins
#363ACTIVATABLE CLOSTRIDIAL TOXINS
#364Cell surface display, screening and production of proteins of interest
#365Antimicrobial Peptide Biocides
#366Innate Immune Receptor Directed Biocides
#367Inhibitors of viral entry screening method
#368Modular transfection systems
#369MODIFIED TRANSFERIN-ANTIBODY FUSION PROTEINS
#370Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers
#371Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
#372Use of VEGF-C or VEGF-D in Reconstructive Surgery
#373Methods of promoting cardiac repair using growth factors fused to heparin binding sequences
#374Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems
#375Use of cell surface displays in yeast cell catalyst supports
#376ACTIVATABLE CLOSTRIDIAL TOXINS
#377Directed evolution of enzymes and antibodies
#378Method for simultaneous display of target protein and cofactor regenerating enzyme on cell surface
#379Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
#380Regulated Stop Codon Readthrough
#381Phage displayed cell binding peptides
#382Cell display of antibody libraries
#383Modified transferrin fusion proteins
#384Modified transferrin fusion proteins
#385Biomolecule partition motifs and uses thereof
#386Multivalent Clostridial toxin derivatives and methods of their use
#387Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
#388Production of heterologous proteins in Caulobacter
#389Regulated transcription of targeted genes and other biological events
#390Helicobacter system and uses thereof
#391Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
#392Regulated apoptosis
#393Lentiviral vectors and uses thereof
#394Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes
#395Cytolysis of target cells by superantigen conjugates inducing T-cell activation
#396Human immunodeficiency virus gp41 mimetibody polypeptides
#397Method for producing protein libraries and for selecting proteins from said libraries
#398Use of VEGF-C or VEGF-D in reconstructive surgery
#399Method for extracellular production of target proteins employing OmpF in
#400Targeted biocides
#401Surface expression of biologically active proteins in bacteria
#402Receptor/histidine kinase fusion constructs and uses thereof